v3.26.1
Restatement of Previously Issued Consolidated Financial Statements - Equity Statement Restatement (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 27, 2025
Sep. 27, 2025
Jun. 28, 2025
Mar. 29, 2025
Dec. 28, 2024
Sep. 28, 2024
Jun. 29, 2024
Mar. 30, 2024
Jun. 28, 2025
Jun. 29, 2024
Sep. 27, 2025
Sep. 28, 2024
Dec. 27, 2025
Dec. 28, 2024
Dec. 30, 2023
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Common stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Preferred stock (in shares) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Preferred stock $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Beginning balance (in shares) 164,531,712 164,274,617 164,274,617 163,842,248 164,531,712 164,531,712 164,531,712   163,842,248   163,842,248   163,842,248    
Beginning balance $ 735,262 $ 685,061 $ 581,435 $ 543,770 $ 876,868 $ 858,600 $ 828,938 826,646 $ 543,770 826,646 $ 543,770 826,646 $ 543,770 826,646  
Share repurchases                             (50,000)
Net income (loss) $ 21,184 55,008 54,044 9,926 $ (306,813) (18,206) 21,626 5,940 63,970 27,566 118,978 9,360 140,162 (297,453) (798,931)
Other comprehensive income (loss)   $ (7,056) $ 38,915 $ 17,483   $ 22,601 $ (3,179) $ (16,399) $ 56,398 $ (19,578) $ 49,342 $ 3,023 $ 54,420 $ (36,184) 23,899
Ending balance (in shares) 164,531,712 164,531,712 164,274,617 164,274,617 163,842,248 164,531,712 164,531,712 164,531,712 164,274,617 164,531,712 164,531,712 164,531,712 164,531,712 163,842,248  
Ending balance $ 767,202 $ 735,262 $ 685,061 $ 581,435 $ 543,770 $ 876,868 $ 858,600 $ 828,938 $ 685,061 $ 858,600 $ 735,262 $ 876,868 $ 767,202 $ 543,770 $ 826,646
Common stock                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance (in shares) 164,454,218 164,274,617 164,274,617 163,842,248 164,113,794 164,082,430 164,079,581 163,965,231 163,842,248 163,965,231 163,842,248 163,965,231 163,842,248 163,965,231 167,404,047
Beginning balance $ 1,645 $ 1,643 $ 1,643 $ 1,638 $ 1,641 $ 1,641 $ 1,641 $ 1,640 $ 1,638 $ 1,640 $ 1,638 $ 1,640 $ 1,638 $ 1,640 $ 1,674
Stock issued relating to Employee Stock Purchase Plan (in shares)   31,912   44,693   29,432   43,764 44,693 43,764 76,605 73,196   73,196 82,546
Stock issued relating to Employee Stock Purchase Plan   $ 0   $ 1   $ 0   $ 0 $ 1 $ 0 $ 1 $ 0 $ 1 $ 0 $ 1
Shares issued for exercise/vesting of share-based compensation awards (in shares)   147,689   393,284   1,932 2,849 170,172 393,284 173,021 540,973 174,953 618,467 256,191 354,093
Shares issued for exercise/vesting of share-based compensation awards   $ 2   $ 4   $ 0 $ 0 $ 2 $ 4 $ 2 $ 6 $ 2 $ 6 $ 3 $ 4
Shares repurchases (in shares)                       0     (3,601,694)
Share repurchases                       $ 0     $ (36)
Forfeiture of restricted stock awards (in shares)       (5,608)       (99,586) (5,608) (99,586) (5,608) (99,586) (5,608) (452,370) (273,761)
Forfeiture of restricted stock awards       $ 0       $ (1) $ 0 $ (1) $ 0 $ (1)   $ (5) $ (3)
Ending balance (in shares) 164,531,712 164,454,218 164,274,617 164,274,617 163,842,248 164,113,794 164,082,430 164,079,581 164,274,617 164,082,430 164,454,218 164,113,794 164,531,712 163,842,248 163,965,231
Ending balance $ 1,645 $ 1,645 $ 1,643 $ 1,643 $ 1,638 $ 1,641 $ 1,641 $ 1,641 $ 1,643 $ 1,641 $ 1,645 $ 1,641 $ 1,645 $ 1,638 $ 1,640
Additional paid-in capital                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance 1,730,738 1,728,491 1,717,824 1,707,573 1,694,648 1,680,775 1,668,916 1,656,166 1,707,573 1,656,166 1,707,573 1,656,166 1,707,573 1,656,166 1,627,681
Stock issued relating to Employee Stock Purchase Plan   438   523   402   502 523 502 961 904 961 904 2,080
Share-based compensation expense   3,089 10,712 12,310   13,489 12,839 12,248 23,022 25,087 26,111 38,576 32,276 52,096 20,288
Exercise of stock options                             6,117
Tax obligations for share-based compensation   (1,280) (45) (2,582)   (18) (980)   (2,627) (980) (3,907) (998) (4,394) (1,593)  
Ending balance 1,736,416 1,730,738 1,728,491 1,717,824 1,707,573 1,694,648 1,680,775 1,668,916 1,728,491 1,680,775 1,730,738 1,694,648 1,736,416 1,707,573 1,656,166
(Accumulated deficit) retained earnings                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance (974,392) (1,029,400) (1,083,444) (1,093,370) (786,557) (768,351) (789,977) (795,917) (1,093,370) (795,917) (1,093,370) (795,917) (1,093,370) (795,917) 52,934
Share repurchases                             (49,920)
Net income (loss)   55,008 54,044 9,926   (18,206) 21,626 5,940 63,970 27,566 118,978 9,360 140,162 (297,453) (798,931)
Ending balance (953,208) (974,392) (1,029,400) (1,083,444) (1,093,370) (786,557) (768,351) (789,977) (1,029,400) (768,351) (974,392) (786,557) (953,208) (1,093,370) (795,917)
Accumulated other comprehensive income (loss)                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance (22,729) (15,673) (54,588) (72,071) (32,864) (55,465) (52,286) (35,887) (72,071) (35,887) (72,071) (35,887) (72,071) (35,887) (59,773)
Other comprehensive income (loss)   (7,056) 38,915 17,483   22,601 (3,179) (16,399) 56,398 (19,578) 49,342 3,023 54,420 (36,184) 23,886
Ending balance (17,651) $ (22,729) $ (15,673) (54,588) (72,071) (32,864) (55,465) (52,286) (15,673) (55,465) (22,729) (32,864) (17,651) (72,071) (35,887)
Non-controlling interests                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance       $ 0 0 0 644 644 $ 0 644 $ 0 644 0 644 631
Other comprehensive income (loss)                             13
Acquisition of non-controlling interest             (644)     (644)   (644)   (644) 13
Ending balance 0       $ 0 $ 0 $ 0 $ 644   $ 0   $ 0 0 $ 0 $ 644
As Previously Reported                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Preferred stock (in shares)   0 0 0 0 0 0 0 0 0 0 0   0 0
Preferred stock   $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0
Beginning balance $ 793,490 743,395 643,243 607,334 962,807 942,790 906,816 906,723 607,334 906,723 607,334 906,723 $ 607,334 906,723  
Net income (loss)   60,862 47,564 5,506   (14,947) 30,159 4,261 53,070 34,420 113,932 19,473   (292,496) (744,962)
Other comprehensive income (loss)   (15,118) 41,343 20,669   21,782 (3,543) (16,532) 62,012 (20,075) 46,894 1,707   (53,697) 24,573
Ending balance   $ 793,490 $ 743,395 $ 643,243 $ 607,334 $ 962,807 $ 942,790 $ 906,816 $ 743,395 $ 942,790 $ 793,490 $ 962,807   $ 607,334 $ 906,723
As Previously Reported | Common stock                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance (in shares) 164,454,218 164,274,617 164,274,617 163,842,248 164,113,794 164,082,430 164,079,581 163,965,231 163,842,248 163,965,231 163,842,248 163,965,231 163,842,248 163,965,231 167,404,047
Beginning balance $ 1,645 $ 1,643 $ 1,643 $ 1,638 $ 1,641 $ 1,641 $ 1,641 $ 1,640 $ 1,638 $ 1,640 $ 1,638 $ 1,640 $ 1,638 $ 1,640 $ 1,674
Stock issued relating to Employee Stock Purchase Plan (in shares)   31,912   44,693   29,432   43,764 44,693 43,764 76,605 73,196   73,196 82,546
Stock issued relating to Employee Stock Purchase Plan   $ 0   $ 1   $ 0   $ 0 $ 1 $ 0 $ 1 $ 0   $ 0 $ 1
Shares issued for exercise/vesting of share-based compensation awards (in shares)   147,689   393,284   1,932 2,849 170,172 393,284 173,021 540,973 174,953   256,191 354,093
Shares issued for exercise/vesting of share-based compensation awards   $ 2   $ 4   $ 0 $ 0 $ 2 $ 4 $ 2 $ 6 $ 2   $ 3 $ 4
Shares repurchases (in shares)                       0     (3,601,694)
Share repurchases                       $ 0     $ (36)
Forfeiture of restricted stock awards (in shares)       (5,608)       (99,586) (5,608) (99,586) (5,608) (99,586)   (452,370) (273,761)
Forfeiture of restricted stock awards       $ 0       $ (1) $ 0 $ (1) $ 0 $ (1)   $ (5) $ (3)
Ending balance (in shares)   164,454,218 164,274,617 164,274,617 163,842,248 164,113,794 164,082,430 164,079,581 164,274,617 164,082,430 164,454,218 164,113,794   163,842,248 163,965,231
Ending balance   $ 1,645 $ 1,643 $ 1,643 $ 1,638 $ 1,641 $ 1,641 $ 1,641 $ 1,643 $ 1,641 $ 1,645 $ 1,641   $ 1,638 $ 1,640
As Previously Reported | Additional paid-in capital                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance 1,725,174 1,720,825 1,709,580 1,699,851 1,687,948 1,674,766 1,664,764 1,652,401 1,699,851 1,652,401 1,699,851 1,652,401 1,699,851 1,652,401 1,628,904
Stock issued relating to Employee Stock Purchase Plan   438   523   402   502 523 502 961 904   904 2,080
Share-based compensation expense   5,191 11,290 11,788   12,798 10,982 11,861 23,078 22,843 28,269 35,641   48,139 15,300
Exercise of stock options                             6,117
Tax obligations for share-based compensation   (1,280) (45) (2,582)   (18) (980)   (2,627) (980) (3,907) (998)   (1,593)  
Ending balance   1,725,174 1,720,825 1,709,580 1,699,851 1,687,948 1,674,766 1,664,764 1,720,825 1,674,766 1,725,174 1,687,948   1,699,851 1,652,401
As Previously Reported | (Accumulated deficit) retained earnings                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance (888,651) (949,513) (997,077) (1,002,583) (690,614) (675,667) (705,826) (710,087) (1,002,583) (710,087) (1,002,583) (710,087) (1,002,583) (710,087) 84,795
Share repurchases                             (49,920)
Net income (loss)   60,862 47,564 5,506   (14,947) 30,159 4,261 53,070 34,420 113,932 19,473   (292,496) (744,962)
Ending balance   (888,651) (949,513) (997,077) (1,002,583) (690,614) (675,667) (705,826) (949,513) (675,667) (888,651) (690,614)   (1,002,583) (710,087)
As Previously Reported | Accumulated other comprehensive income (loss)                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance (44,678) (29,560) (70,903) (91,572) (36,168) (57,950) (54,407) (37,875) (91,572) (37,875) (91,572) (37,875) (91,572) (37,875) (62,435)
Other comprehensive income (loss)   (15,118) 41,343 20,669   21,782 (3,543) (16,532) 62,012 (20,075) 46,894 1,707   (53,697) 24,560
Ending balance   $ (44,678) $ (29,560) (70,903) (91,572) (36,168) (57,950) (54,407) (29,560) (57,950) (44,678) (36,168)   (91,572) (37,875)
As Previously Reported | Non-controlling interests                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance       $ 0 0 0 644 644 $ 0 644 $ 0 644 0 644 631
Acquisition of non-controlling interest             (644)     (644)   (644)   (644) 13
Ending balance         $ 0 $ 0 $ 0 $ 644   $ 0   $ 0   $ 0 $ 644
Restatement Impacts                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Preferred stock (in shares)   0 0 0 0 0 0 0 0 0 0 0   0 0
Preferred stock   $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0
Beginning balance $ (58,228) (58,334) (61,808) (63,564) (85,939) (84,190) (77,878) (80,077) (63,564) (80,077) (63,564) (80,077) $ (63,564) (80,077)  
Net income (loss)   (5,854) 6,480 4,420   (3,259) (8,533) 1,679 10,900 (6,854) 5,046 (10,113)   (4,957) (53,969)
Other comprehensive income (loss)   8,062 (2,428) (3,186)   819 364 133 (5,614) 497 2,448 1,316   17,513 (674)
Ending balance   $ (58,228) $ (58,334) $ (61,808) $ (63,564) $ (85,939) $ (84,190) $ (77,878) $ (58,334) $ (84,190) $ (58,228) $ (85,939)   $ (63,564) $ (80,077)
Restatement Impacts | Common stock                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance (in shares) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Beginning balance $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Stock issued relating to Employee Stock Purchase Plan (in shares)   0   0   0   0 0 0 0 0   0 0
Stock issued relating to Employee Stock Purchase Plan   $ 0   $ 0   $ 0   $ 0 $ 0 $ 0 $ 0 $ 0   $ 0
Shares issued for exercise/vesting of share-based compensation awards (in shares)   0   0   0 0 0 0 0 0 0   0 0
Shares issued for exercise/vesting of share-based compensation awards   $ 0   $ 0   $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0
Shares repurchases (in shares)                       0     0
Share repurchases                       $ 0     $ 0
Forfeiture of restricted stock awards (in shares)       0       0 0 0 0 0   0 0
Forfeiture of restricted stock awards       $ 0       $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0
Ending balance (in shares)   0 0 0 0 0 0 0 0 0 0 0   0 0
Ending balance   $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0
Restatement Impacts | Additional paid-in capital                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance 5,564 7,666 8,244 7,722 6,700 6,009 4,152 3,765 7,722 3,765 7,722 3,765 7,722 3,765 (1,223)
Stock issued relating to Employee Stock Purchase Plan   0   0   0   0 0 0 0 0   0 0
Share-based compensation expense   (2,102) (578) 522   691 1,857 387 (56) 2,244 (2,158) 2,935   3,957 4,988
Exercise of stock options                             0
Tax obligations for share-based compensation   0 0 0   0 0   0 0 0 0   0  
Ending balance   5,564 7,666 8,244 7,722 6,700 6,009 4,152 7,666 6,009 5,564 6,700   7,722 3,765
Restatement Impacts | (Accumulated deficit) retained earnings                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance (85,741) (79,887) (86,367) (90,787) (95,943) (92,684) (84,151) (85,830) (90,787) (85,830) (90,787) (85,830) (90,787) (85,830) (31,861)
Share repurchases                             0
Net income (loss)   (5,854) 6,480 4,420   (3,259) (8,533) 1,679 10,900 (6,854) 5,046 (10,113)   (4,957) (53,969)
Ending balance   (85,741) (79,887) (86,367) (90,787) (95,943) (92,684) (84,151) (79,887) (92,684) (85,741) (95,943)   (90,787) (85,830)
Restatement Impacts | Accumulated other comprehensive income (loss)                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance $ 21,949 13,887 16,315 19,501 3,304 2,485 2,121 1,988 19,501 1,988 19,501 1,988 19,501 1,988 2,662
Other comprehensive income (loss)   8,062 (2,428) (3,186)   819 364 133 (5,614) 497 2,448 1,316   17,513 (674)
Ending balance   $ 21,949 $ 13,887 16,315 19,501 3,304 2,485 2,121 13,887 2,485 21,949 3,304   19,501 1,988
Restatement Impacts | Non-controlling interests                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Beginning balance       $ 0 0 0 0 0 $ 0 0 $ 0 0 $ 0 0 0
Acquisition of non-controlling interest             0     0   0   0 0
Ending balance         $ 0 $ 0 $ 0 $ 0   $ 0   $ 0   $ 0 $ 0